Sigma-Aldrich to Buy U.S. Biopharma Services Firm for $350 Million
16:57 PM | January 9, 2012 | Alex Scott
Sigma-Aldrich has agreed to acquire BioReliance Holdings (Rockville, MD), a provider of global biopharmaceutical testing services, for $350 million in cash from Avista Capital Partners (New York)...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.